Editas Medicine, Inc. 4
4 · Editas Medicine, Inc. · Filed Feb 9, 2016
Insider Transaction Report
Form 4
Nikolic Boris
Director
Transactions
- Conversion
Common Stock
2016-02-08+2,649,572→ 2,649,572 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2016-02-08+6,888,888→ 0 total(indirect: See Footnote)→ Common Stock (2,649,572 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock converted into Common Stock on a 2.6-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock wasconvertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]These shares are owned by bng0, LLC. Boris Nikolic, as a member and the managing director of bng0, LLC, has voting and investment power over such shares and may be deemed the indirect beneficial owner of such shares. Boris Nikolic disclaims beneficial ownership over such shares, except to the extent of any pecuniary interest therein.